Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The potassium channel protein Kir3.x subunit, also known as IKACh, is part of the G protein-gated inwardly rectifying potassium (GIRK) channel family. These channels are crucial regulators of cellular excitability in both the heart and nervous system. Functional channels are tetramers formed by combinations of Kir3.1, Kir3.2, Kir3.3, and Kir3.4 subunits. Activation occurs via Gβγ dimers released upon activation of Gi/o-coupled G-protein coupled receptors (GPCRs). IKACh mediates parasympathetic slowing of heart rate and modulates inhibitory postsynaptic potentials in neurons.
Indirectly modulated via drugs targeting upstream GPCRs
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium Channel Protein Kir3.x Subunit (IKACh) (IKACh).